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Associate Director, Cytogenetics.—The Department of
Cytogenetics of Quest Diagnostics, Inc. at the Nichols
Institute in San Juan Capistrano, CA, seeks an Associate
Director to join the management team of their expand-
ing, high-volume laboratory. The department offers a
comprehensive test menu including CVS, amniotic fluid,
products of conception, peripheral blood, Fanconi ane-
mia, and SCE studies, as well as oncology, FISH, and
spectral karyotyping. The department also has an active
research and development program and opportunities to
participate in projects leading to presentations and sci-
entific publications. Full benefits offered by Quest in-
clude medical/dental insurance, 401K, employee stock
programs, and other incentives. An M.D. or Ph.D. with
ABMG certification in clinical cytogenetics is required;
other ABMG certification (in clinical molecular genetics,
clinical genetics, or another specialty) would be desirable
but is not required. Responsibilities of the position in-
clude case reporting and sign-out, consultation with re-
ferring physicians and counselors, and participation in
staff educational activities and projects. Communica-
tions should be directed to Arturo Anguiano, M.D.,
Medical Director, Department of Cytogenetics, Quest
Diagnostics, Inc., Nichols Institute, 33608 Ortega High-
way, San Juan Capistrano, CA 92690; telephone: (800)
642-4657 ext. #4538; fax: (949) 728-4979.
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Postdoctoral Position, McKusick-Nathans Institute of
Genetic Medicine, Johns Hopkins University School of
Medicine.—Nail patella syndrome (NPS) is a diverse
phenotype characterized by dysplasia of the nails, pa-
tellae, and elbows, as well as open-angle glaucoma and
potentially lethal nephropathy. It has been established
that NPS is the result of heterozygous loss-of-function
mutations in the LIM-homeodomain transcription fac-
tor, LMX1B. An NIH-funded position is available im-
mediately to investigate the role of LMX1B in both
normal and abnormal mammalian development. Further
information is available at http://www.med.jhu.edu/nps/
index.html and Hum Mutat 14:459–465 (1999). Ph.D.
or equivalent is required; previous experience in pro-
moter analysis, transgenic mouse development, in situ
hybridization, and/or yeast two hybrid analysis would
be helpful. Salary will be commensurate with experience.
Applications, with the names of three references, should
be sent to Iain McIntosh, Ph.D., McKusick-Nathans In-
stitute of Genetic Medicine, Johns Hopkins University,
600 North Wolfe Street, Blalock 1012G, Baltimore MD
21287-4922, USA. E-mail: imcintos@welch.jhu.edu;
fax: (410) 614-2522. Johns Hopkins University is an
equal opportunity employer.
Researcher in Microarray Data.—The successful can-
didate will conduct research in the analysis of DNA mi-
croarray data, including the development and testing of
new computational techniques, as well as the application
of new and existing techniques to microarray expression
data. Candidates should have a strong research history
in biology and solid programming skills, with knowledge
of C, C, Java, Perl, and Unix. The successful can-
didate will be expected to work alone and in teams.
Ph.D. in biology or a related area is required. Salary is
competitive. Send your resume to Dr. T. Conrad Gilliam,
Co-Director, Columbia Genome Center, Russ Berrie
Medical Pavilion, 1150 St. Nicholas Ave., New York,
NY 10032. Unit 109: telephone (212) 304-7986; fax
(212) 304-5515; e-mail: tcg1@columbia.edu. Columbia
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Postdoctoral Positions in Genetic Epidemiology.—The
Genetics Program at Boston University School of Med-
icine is seeking researchers to participate in ongoing and
new projects aimed at understanding the genetic basis
of complex diseases. Current foci include molecular
genetic studies of hypertension and a large multicenter
genetic epidemiological study of Alzheimer disease,
headquartered at Boston University. Other opportunities
for training and research are available in ongoing link-
age-mapping studies of several disease loci, including
those for Alzheimer disease, metabolic syndrome, co-
caine dependence, and birth defects (especially, nonsyn-
dromic cleft lip and palate). The research environment
is enhanced by a new Genetic Epidemiology Center fea-
turing state-of-the-art computing facilities, an interactive
group including six faculty-level genetic epidemiologists,
strong epidemiology and biostatistics programs in the
School of Public Health, the emergence within the Ge-
netics Program of a molecular-genetics core facility en-
abling genetics research in large patient populations, and
collaborative ties with the Framingham Study. A strong
background in a quantitative science is required; expe-
rience in genetics or a related field is recommended. Pref-
erence will be given to applicants meeting residency re-
quirements for sponsorship from an NIH training grant.
Send a curriculum vitae and three letters of recommen-
dation to Dr. Lindsay Farrer, Chief, Genetics Program,
Boston University School of Medicine, 715 Albany
Street, Boston, MA 02118; telephone: (617) 638-5393;
fax: (617) 638-4275; e-mail: farrer@neugen.bu.edu.
Boston University is an affirmative action/equal oppor-
tunity employer.
FELLOWSHIP OPPORTUNITY
Postdoctoral Fellowship in Behavioral Genetics.—We
anticipate that at least one postdoctoral fellowship will
become available, from July 1, 2000, for persons inter-
ested in the quantitative or molecular analysis of com-
plex traits. The fellowship will be supported by an
NIDA-funded research center focusing on “Antisocial
Drug Dependence: Genetics and Treatment” (principal
investigator: T. J. Crowley), and fellows will be expected
to do research related to the genetic and environmental
etiology of substance dependence and/or problem be-
havior during adolescence. Experience with quantitative
behavior genetic modeling, QTL analysis, or pedigree
analysis would be an advantage. This fellowship would
be based primarily at the Institute for Behavioral Ge-
netics, in Boulder, and would be supervised by J. K.
Hewitt, M. C. Stallings, or R. P. Corley. Expressions
of initial interest should be directed to one of these
individuals at John.Hewitt@colorado.edu, Michael.
Stallings@colorado.edu, or Robin.Corley@colorado
.edu, respectively. The center is a collaboration between
the Institute for Behavioral Genetics; the Addiction Re-
search and Treatment Service; and the Department of
Molecular, Cellular, and Developmental Biology of the
University of Colorado (Boulder and Denver campuses).
We are currently conducting twin and adoption studies
and QTL sib analyses of clinical populations aimed at
defining genetic mechanisms and gene loci contributing
to the clinical conditions of conduct disorder, antisocial
personality disorder, and substance dependence. Senior
faculty include T. J. Crowley (Psychiatry); J. K. Hewitt,
R. P. Corley, and M. C. Stallings (Behavioral Genetics);
Paula Riggs (Psychiatry); and K. S. Krauter (Molecular
Genetics).
CONFERENCE
European Human Genetics Conference, Amsterdam,
May 27–30, 2000.—This international conference (now
in its 32d year) is a forum for all workers in human and
medical genetics. It is the place to gain an overview of
current advances and to develop research collaborations
in all fields of genetics, includingmolecular genetics, clin-
ical genetics, cytogenetics, population and quantitative
genetics, biochemical genetics, and developmental ge-
netics. The Scientific Program will include invited lec-
tures from A. Brice, K. Bushby, H. Cooke, K. Devriendt,
A. Feinberg, D. Fitzpatrick, R. Fodde, A. Geurts van
Kessel, A. Goldberg, N. Gregersen, P. Guicheney, I. Han-
son, P. Harper, U. Hartl, A. Helenius, A. Karmiloff
Smith, B. Knoppers, I. Liebaers, R.McInnes, C.Mecucci,
M. Pirastu, R. Plasterk, M. Richards, A. Rosenthal, J.
Satsangi, D. Shore, J. Terwilliger, M. Uhle´n, C. Van
Broeckhoven, G. Vriend, B. Weber, J. Weissenbach, B.
Wieringa, C. Wijmenga, E. Wolf, M. Zeviani, and O.
Zuffardi; workshops on current topics; a late-breaking
research session; and posters. Young Scientist Awards
and Conference Fellowships for young researchers will
be available. Further details about the provisional pro-
gram, registration, and accommodations are available
on theWeb site (http://www.eurocongres.com/eshg).The
European Society of Human Genetics promotes research
in basic and applied human and medical genetics and
facilitates contact between all persons who share these
aims. President: Jean-Louis Mandel; Scientific-Program
Committee Chairman: AndrewRead; Secretary-General:
Peter Farndon; local host: Gert-Jan van Ommen. Meet-
ing organizer: Eurocongres Conference Management,
Jan van Goyenkade 11, NL-1075 HP Amsterdam; tel-
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.com. Exhibition, Sponsoring, Satellites: Rose Interna-
tional, P.O. Box 93260, NL-2509 AG The Hague; tel-
ephone 31 70 383 8901; e-mail: roseint@euronet.nl
SEMINAR
The Tenth International Clinical Genetics Seminar.—
“Genetics in Primary Care” is the main theme of the
Tenth International Clinical Genetics Seminar, to be held
in Amman, Jordan, October 20–24, 2000. Further in-
formation can be obtained from Professor Mohammed
El-Khateeb, Department of Pathology and Microbiol-
ogy, University of Jordan/NCDEG, P.O. Box 13002,




Workshop on Hallervorden-Spatz syndrome (HSS) to be
held at NIH on May 19 and 20, 2000. Topics will in-
clude “Clinical Delineation of HSS,” “Pigmentary Ret-
inopathy in HSS,” “Pathology of HSS,” “Genetics of
HSS,” “Systemic Iron Transport and Metabolism,”
“Brain Iron Transport and Metabolism,” “The Basal
Ganglia,” “Overlap of HSS and Neurodegenerative Syn-
dromes with RP—Clues to Pathogenesis?,” “Hypotheses
of HSS Pathogenesis,” “Therapeutic Approaches,” and
“HSS Research Priorities.” For more information or reg-
istration, contact Patty Wood, Workshop Coordinator,
at (619) 588-2315 or Susan Hayflick, M.D., Chair, Sci-
entific Organizing Committee, at (503) 494-7703.
